Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
United States: 1-888-708-7444 or 1-919-852-4685
France: +33 1 56 95 17 10
Germany: +49 89 45 10 300
United Kingdom: +44 (0) 114 292 2322
India: +91 984 500 6625
Interested in Certara's biosimulation solutions? Want to speak to someone in our sales team? Click on the link below!
Certara’s clinical trial outcome databases support Model-Based Meta-Analysis. Two main areas of application are comparative effectiveness and scaling of endpoints. The understanding gained from the analysis of these databases has many uses. It can help optimize dosing. It also enables quantifying the drug’s benefits relative to competing treatment options. Finally, it helps users to predict their drug’s probability of success. Better understanding of a new compound’s characteristics relative to competitors also facilitates decision-making. The databases cover many therapeutic areas. These include central nervous system (CNS), cardiovascular, immunology, metabolic diseases, and pain.
Certara Strategic Consulting is expanding our databases into other therapeutic areas. Clients may license the existing databases. Certara can also build new ones in areas critical to our clients’ product portfolios. The quality of information impacts the quality of decisions. Certara’s high quality, up-to-date databases help inform important drug development decisions.